Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations
Article in Applied Health Economics and Health Policy (February 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Nutzen der Labormedizin in der Schweiz
Monograph (January 2023)
Nivolumab Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
Article in Frontiers in Pharmacology (July 2022)